AI기업정보

AI 신약개발기업 상세

(주)디파이브테라퓨틱스 AI신약융합연구원 | 2023-11-22
조회수 736
  • 오용호
  • 031-759-9920
  • byjung@d5tx.com
기업소개 기업소식 모아보기 홈페이지 바로가기
프로세스

Target Identification Drug Discovery Pre Clinical

의약품

합성 의약품


1. 합성치사 항암제 개발

 2. 합성치사 관계 유전자 타겟 및 바이오마커 예측 플랫폼 보유


D5 Therapeutics is a leading biotechnology company that is discovering novel target and developing innovative medicines  in a conceptual frame of synthetic
lethality leveraging data-driven platform technology.

We identify and validate potential SL targets and characterize SL interactions through D5’s comprehensive SL prediction platform that integrated computational and
experimental framework.

With D5’s platform, we will not only expand our SL pipeline but also collaborate with a various global partners to develop more accurate and effective treatment options for
cancer patients.